MENU
TBPH
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Theravance Biopharma (TBPH) Earnings Date & Reports

Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives... Show more

A.I. Advisor
published Earnings

TBPH is expected to report earnings to fall 172.00% to 7 cents per share on August 05

Theravance Biopharma TBPH Stock Earnings Reports
Q2'26
Est.
$0.07
Q1'26
Missed
by $0.07
Q4'25
Beat
by $0.15
Q3'25
Beat
by $0.20
Q2'25
Beat
by $0.41
The last earnings report on May 07 showed earnings per share of -10 cents, missing the estimate of -2 cents. With 72.05K shares outstanding, the current market capitalization sits at 854.23M.
View a ticker or compare two or three
TBPH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of small molecule pharmaceutical products

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Other
Address
Ugland House, South Church Street
Phone
+1 650 808-6000
Employees
99
Web
https://www.theravance.com